Announcements Trials

Browse Landscape

Status

Recruiting 2 Unknown 1 Suspended 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Melanoma 8 Carcinoma, Non-Small-Cell Lung 6 Breast Neoplasms 5 Pancreatic Neoplasms 4 Neoplasms 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Prostatic Neoplasms 3 Head and Neck Neoplasms 3 Esophageal Neoplasms 3 Carcinoma, Basal Cell 3 Barrett Esophagus 3 Squamous Cell Carcinoma of Head and Neck 2 Rectal Neoplasms 2 Ovarian Neoplasms 2 Neuroendocrine Tumors 2 Lung Neoplasms 2 Liver Neoplasms 2 Inflammatory Bowel Diseases 2 Colonic Neoplasms 2 Breast Neoplasms, Male 2 Uveal Melanoma 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Tuberculosis 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Squamous Intraepithelial Lesions 1 Small Cell Lung Carcinoma 1

Interventions

Gefitinib 9 Pemetrexed 7 Carboplatin 5 Gemcitabine 4 Cisplatin 4 apatinib 3 Docetaxel 3 aflutinib 2 Neoadjuvant Therapy 2 Erlotinib Hydrochloride 2 Bevacizumab 2 tislelizumab 1 pembrolizumab 1 motesanib diphosphate 1 lometrexol 1 icotinib 1 endostar protein 1 camrelizumab 1 Watchful Waiting 1 Thymalfasin 1 Radiomics 1 Platinum Compounds 1 Paclitaxel 1 Lymph Node Excision 1 Indium 1 Immune Checkpoint Inhibitors 1 High-Throughput Nucleotide Sequencing 1 Folic Acid 1 Exome 1 Exercise 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Adenocarcinoma of Lung × Biopsy × Clear all

NCT02898857 2016-09-13

NOTCH

University Hospital, Montpellier

Adenocarcinoma of Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡